EUVIMEDEUVIMED entdecken
Kohortenstudie

Impact of Bronchiectasis Severity on Clinical Outcomes in Patients With Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study

Inderpaul S Sehgal, Valliappan Muthu, Sahajal Dhooria, Kuruswamy T Prasad, Mandeep Garg, Shivaprakash M Rudramurthy, Ashutosh N Aggarwal, Arunaloke Chakrabarti, Ritesh Agarwal

The Journal of Allergy and Clinical Immunology: In Practice · 2025

DOI: 10.1016/j.jaip.2025.03.005 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2025. Verfasst von Inderpaul S Sehgal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Hauptthemen laut MEDLINE: Aspergillosis, Allergic Bronchopulmonary, Bronchiectasis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The impact of bronchiectasis severity on the outcomes of patients with allergic bronchopulmonary aspergillosis (ABPA) remains uncertain. OBJECTIVE: To evaluate whether bronchiectasis severity is associated with an increased risk of ABPA exacerbations. METHODS: We retrospectively analyzed patients with ABPA between 2007 and 2019. Patients were categorized based on the segments involved by bronchiectasis as mild (1-5), moderate (6-9), and extensive (≥10). We compared lung function and immunological markers among the groups. A multivariable Poisson regression analysis, using follow-up duration as an offset variable, assessed the association between bronchiectasis severity and ABPA exacerbations, adjusting for key confounders. We report the association as an adjusted relative rate (aRR) with 95% confidence intervals (CI). RESULTS: We included 705 patients with ABPA (mean age, 35 years). Of these, 219 (31.1%), 226 (32.1%), and 260 (36.9%) had mild, moderate, and extensive bronchiectasis, respectively. Patients with extensive bronchiectasis had poorer lung function and elevated immunological markers (serum total IgE, Aspergillus fumigatus-IgE, and A. fumigatus-IgG) than those with mild or moderate bronchiectasis. The exacerbation frequency increased with the severity of bronchiectasis (mild: 41.5% vs moderate: 53.4% vs extensive: 57.7%, P = .005). On multivariable analysis, the risk of ABPA exacerbation increased significantly with bronchiectasis severity (aRR [95% CI]; extensive: 1.51 [1.09-2.08], moderate: 1.50 [1.09-2.08]). In addition, increasing age (aRR, 0.84 [95% CI, 0.76-0.94]) and body mass index (aRR, 0.97 [95% CI, 0.94-0.99]) were associated with lower exacerbation risk after adjusting for total IgE, lung function, and high-attenuation mucus. CONCLUSION: Moderate-to-extensive bronchiectasis is associated with worse lung function, heightened immunological severity, and an increased risk of ABPA exacerbation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aspergillosis, Allergic BronchopulmonaryBronchiectasisHumansMaleFemaleRetrospective StudiesAdultSeverity of Illness IndexMiddle AgedImmunoglobulin EDisease Progression

Stichwörter der Autor:innen

AllergyAspergillosisAsthmaFungal ballFungal sensitization

Substanzen

Immunoglobulin E

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Doodhadhari Burfani Hospital, Haridwar, Uttarakhand, India.
  • Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Electronic address: agarwal.ritesh@outlook.in.

Zitieren

APA

Sehgal, I. S., Muthu, V., Dhooria, S., Prasad, K. T., Garg, M., Rudramurthy, S. M., Aggarwal, A. N., Chakrabarti, A., & Agarwal, R. (2025). Impact of Bronchiectasis Severity on Clinical Outcomes in Patients With Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2025.03.005

Vancouver

Sehgal IS, Muthu V, Dhooria S, Prasad KT, Garg M, Rudramurthy SM, et al. Impact of Bronchiectasis Severity on Clinical Outcomes in Patients With Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study. The Journal of Allergy and Clinical Immunology: In Practice. 2025. doi:10.1016/j.jaip.2025.03.005

BibTeX
@article{Sehgal2025,
  author = {Sehgal, Inderpaul S and Muthu, Valliappan and Dhooria, Sahajal and Prasad, Kuruswamy T and Garg, Mandeep and Rudramurthy, Shivaprakash M and Aggarwal, Ashutosh N and Chakrabarti, Arunaloke and Agarwal, Ritesh},
  title = {Impact of Bronchiectasis Severity on Clinical Outcomes in Patients With Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2025},
  doi = {10.1016/j.jaip.2025.03.005}
}
Kostenlos starten →